Medicine and Dentistry
Hemodialysis
100%
Lupus Nephritis
86%
End Stage Renal Disease
61%
Systemic Lupus Erythematosus
49%
Acute Kidney Injury
40%
Renal Biopsy
37%
Human Immunodeficiency Virus
36%
Biological Marker
35%
Arterial Stiffness
33%
Cardiovascular Disease
32%
Creatinine
29%
Electrocardiogram
26%
Proteomics
26%
Cardiovascular System
24%
Artery Calcification
24%
Personalized Medicine
24%
Medicine
24%
COVID-19
24%
Biopsy
23%
Infection
22%
Proteinuria
21%
Chronic Kidney Disease
18%
Kidney Injury
18%
Pulse Wave Velocity
18%
Adverse Event
18%
Mycophenolic Acid
18%
Disease
17%
All Cause Mortality
17%
Transcriptomics
16%
Diabetes Mellitus
15%
Sudden Cardiac Death
15%
Hazard Ratio
13%
Cardiovascular Risk
13%
Diabetes
12%
Arrhythmia
12%
Continuous Hemodialysis
12%
Mesangial Proliferative Glomerulonephritis
12%
Magnesium
12%
Osteoprotegerin
12%
Liver Graft
12%
Disease Course
12%
Interleukin 16
12%
Microangiopathy
12%
Lupus Erythematosus
12%
Subdural Hematoma
12%
Sleep Disorder
12%
Fibroblast Growth Factor 23
12%
Vascular Disease
12%
Cancer Risk
12%
Abdominal Obesity
12%
Keyphrases
Lupus Nephritis
75%
Hemodialysis
37%
Incident Hemodialysis
30%
Confidence Interval
26%
End-stage Renal Disease
24%
Incident Hemodialysis Patients
24%
Arterial Calcification
24%
Fibroblast Growth Factor 23 (FGF23)
24%
New Onset
24%
Urine Proteome
24%
Arterial Stiffness
24%
Kidney Biopsy
24%
Chronic Kidney Disease
21%
Pulse Wave Velocity
20%
Cardiovascular Mortality
18%
Acute Kidney Injury
18%
COVID-19
18%
Mycophenolate Mofetil
18%
All-cause Mortality
17%
End-stage Kidney Disease
16%
Cardiovascular Risk
15%
Systemic Lupus Erythematosus
15%
Clinically Indicated
15%
Hospitalization
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Single-cell Transcriptomics
14%
Single Center
13%
Urinary Biomarkers
13%
Dialysis Patients
13%
Non-associated
12%
Hazard Ratio
12%
Recovery Time
12%
Intermittent Hemodialysis
12%
Precision Medicine Research
12%
Risk Profile
12%
Hematoma Expansion
12%
Coronavirus Disease (COVID)
12%
Membranous Nephritis
12%
Membranoproliferative Glomerulonephritis
12%
Continuous Veno-venous Hemodialysis
12%
Multi-ethnic
12%
Renal Thrombotic Microangiopathy
12%
Cardiovascular Implications
12%
Functional Outcomes of Sleep Questionnaire
12%
Patient Perspective
12%
Post-dialysis
12%
Individual Design
12%
Transformation Time
12%
Calciprotein Particles
12%
Cancer Risk
12%